LITHIUM

The LITHIUM test provides accurate at‑home measurement of blood lithium concentration to support safe therapeutic monitoring for patients on lithium therapy. Samples are collected at your residence by trained phlebotomists and analyzed in a certified Dubai laboratory, delivering clinically validated results with confidentiality and rapid turnaround. Regular lithium monitoring is essential because lithium has a narrow therapeutic window—timely testing helps prevent toxicity and ensures effective dosing.

This test is recommended for people receiving lithium for mood disorders (for example, bipolar disorder) after dose changes, when starting or stopping interacting medications, or if symptoms of toxicity or inadequate effect appear. Results are formatted for clinician interpretation and can be shared securely with your treating physician in the UAE to guide dose adjustments and ongoing care.

• Serum Lithium (Li) concentration (mmol/L)
• Capillary blood Lithium concentration (where applicable)
• Trough lithium level (12‑hour post‑dose measurement)

• After initiating lithium therapy or changing the dose
• At steady state (typically 5–7 days after a dose change)
• If symptoms suggest lithium toxicity (nausea, tremor, ataxia, confusion)
• When starting or stopping interacting drugs (NSAIDs, diuretics, ACE inhibitors)
• With decline or changes in renal function
• During pregnancy planning or when pregnant (under physician guidance)

• Home sample collection by trained phlebotomists for patient convenience
• Analysis in a certified Dubai laboratory for clinical‑grade accuracy
• Fast, confidential digital delivery of results to patient and clinician
• Trough‑level reporting aligned with therapeutic reference ranges
• Helps clinicians make timely dose adjustments to reduce risk of toxicity

• At‑home blood sample collection (capillary or venous) by a certified technician
• Preferably draw sample 12 hours after the last lithium dose (trough level)
• No fasting required; remain normally hydrated unless instructed otherwise
• Inform the phlebotomist/clinic of all medications, supplements, and recent renal status changes